Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique
- PMID: 29317811
- PMCID: PMC5743112
- DOI: 10.2147/COPD.S150853
Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique
Abstract
Existing data on COPD prevalence are limited or totally lacking in many regions of Europe. The geographic information system inverse distance weighted (IDW) interpolation technique has proved to be an effective tool in spatial distribution estimation of epidemiological variables, when real data are few and widely separated. Therefore, in order to represent cartographically the prevalence of COPD in Europe, an IDW interpolation mapping was performed. The point prevalence data provided by 62 studies from 19 countries (21 from 5 Northern European countries, 11 from 3 Western European countries, 14 from 5 Central European countries, and 16 from 6 Southern European countries) were identified using validated spirometric criteria. Despite the lack of data in many areas (including all regions of the eastern part of the continent), the IDW mapping predicted the COPD prevalence in the whole territory, even in extensive areas lacking real data. Although the quality of the data obtained from some studies may have some limitations related to different confounding factors, this methodology may be a suitable tool for obtaining epidemiological estimates that can enable us to better address this major public health problem.
Keywords: GIS; Geographic Resources Analysis Support System; epidemiology; geographic information system.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures



Similar articles
-
Geographical Distribution of COPD Prevalence in the Americas.COPD. 2018 Jun-Aug;15(4):317-325. doi: 10.1080/15412555.2018.1481936. Epub 2018 Oct 30. COPD. 2018. PMID: 30375898
-
Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia.Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1100-1106. doi: 10.5588/ijtld.19.0015. Int J Tuberc Lung Dis. 2019. PMID: 31627775
-
Influence of country-level differences on COPD prevalence.Int J Chron Obstruct Pulmon Dis. 2016 Sep 19;11:2305-2313. doi: 10.2147/COPD.S113868. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27698561 Free PMC article.
-
Prevalence of α1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review.Eur Respir Rev. 2020 Jul 21;29(157):200014. doi: 10.1183/16000617.0014-2020. Print 2020 Sep 30. Eur Respir Rev. 2020. PMID: 32699024 Free PMC article.
-
Burden and clinical features of chronic obstructive pulmonary disease (COPD).Lancet. 2004 Aug 14-20;364(9434):613-20. doi: 10.1016/S0140-6736(04)16855-4. Lancet. 2004. PMID: 15313363 Review.
Cited by
-
The Cost-Effectiveness of Pulmonary Rehabilitation for COPD in Different Settings: A Systematic Review.Appl Health Econ Health Policy. 2021 May;19(3):313-324. doi: 10.1007/s40258-020-00613-5. Epub 2020 Oct 20. Appl Health Econ Health Policy. 2021. PMID: 33079374
-
Time Series Analysis and Forecasting with Automated Machine Learning on a National ICD-10 Database.Int J Environ Res Public Health. 2020 Jul 10;17(14):4979. doi: 10.3390/ijerph17144979. Int J Environ Res Public Health. 2020. PMID: 32664331 Free PMC article.
-
Cross-Cultural Adaptation Of The Persian Version Of Test Of The Adherence To Inhalers (TAI).Patient Prefer Adherence. 2019 Oct 3;13:1693-1699. doi: 10.2147/PPA.S222096. eCollection 2019. Patient Prefer Adherence. 2019. PMID: 31631984 Free PMC article.
-
Point-of-care ultrasound induced changes in management of unselected patients in the emergency department - a prospective single-blinded observational trial.Scand J Trauma Resusc Emerg Med. 2020 May 29;28(1):47. doi: 10.1186/s13049-020-00740-x. Scand J Trauma Resusc Emerg Med. 2020. PMID: 32471452 Free PMC article.
-
Herb-symptom analysis of Erchen decoction combined with Xiebai powder formula and its mechanism in the treatment of chronic obstructive pulmonary disease.Front Pharmacol. 2023 May 19;14:1117238. doi: 10.3389/fphar.2023.1117238. eCollection 2023. Front Pharmacol. 2023. PMID: 37274103 Free PMC article.
References
-
- GBD 2015 Chronic Respiratory Disease Collaborators Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691–706. - PMC - PubMed
-
- Bernd L, Joan BS, Michael S, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148:971–985. - PubMed
-
- Soriano JB, Rodriguez-Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors and clinical presentation. Proc Am Thorac Soc. 2011;8:363–367. - PubMed